Back to search

Switzerland· 54282044

Xenical, Hartkapseln

A orlistat product containing orlistatum, registered in Switzerland by Cheplapharm Schweiz GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A08AB01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedXenical, HartkapselnATCA08AB01REGISTER NO.54282044PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Orlistat is registered in 16 of 19 countries.

Countries holding a registration under ATC A08AB01 (orlistat), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Orlistat · ATC A08AB01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of orlistat costs, country by country.

Normalised to the WHO defined daily dose (0.36 g), so markets compare like for like.

  • Switzerland: $3.08 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Orlistat · price per daily dose (0.36 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.08
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
orlistatum
Manufacturer
Cheplapharm Schweiz GmbH
Country
Switzerland (CH)
ATC code
A08AB01
ATC class
Orlistat
Defined daily dose
0.36 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680542820446
    84 Stk
    CHF 71.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

374 interactions on record for orlistat.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Orlistat · interactions on record

374 records

  • 9 severe
  • 117 moderate
  • 8 minor
  • 238 info

Most severe, free to view

  • TriheptanoinA16AX17severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Orlistat in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All orlistat products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Belgium · Orlistat Sandoz, Orlistat Teva
  • Czechia · Orlistat 1 A Pharma, Orlistat Sandoz
  • Germany · Orlistat 1 A Pharma, Orlistat Hexal
  • Denmark · Orlistat Accord, Orlistat Rivopharm
  • Estonia · Orlistat Sandoz
  • Spain · Beacita, Elimens
  • Finland · Orlistat Sandoz, Orlistat Stada
  • France · Orlistat Eg
  • United Kingdom (Northern Ireland) · Orlistat, Orlistat Accord-Uk
  • Ireland · Orlistat Accord
  • Iceland · Alli, Xenical
  • Italy · Beacita
  • Liechtenstein · Alli, Xenical
  • Lithuania · Orlistat Polpharma
  • Latvia · Orlistat Polpharma
  • Netherlands · Orlistat Sandoz
  • Norway · Alli, Orlistat Accord
  • Portugal · Orlistato Beacita, Orlistato Ciclum
  • Sweden · Beacita, Orlistat Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dc41ddee-6017-4f78-8b44-250c0f0dd137
GET /v1/drugs/dc41ddee-6017-4f78-8b44-250c0f0dd137?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "orlistatum 120 mg",
  "valid_from": "2003-06-01",
  "limitations": "[{\"description\":\"Mindestens BMI 28<br>\\nNur für die Behandlung von adipösen Patienten mit Diabetes Typ II, die gleichzeitig mit einem/mehreren oralen Antidiabetikum/Antidiabetika behandelt werden. Die Behandlung muss nach 6 Monaten abgebrochen werden, wenn der Gewichtsverlust nicht mindestens 5 kg des Körpergewichts zu Beginn der Medikation und/oder die Reduktion des HbA1c-Wertes nicht mindestens 0,5% beträgt. Bei Erreichen des Ziels wird die Therapie bis auf maximal 2 Jahre verlängert.<br>\\nVorgängige Kostengutsprache durch den Vertrauensarzt des Krankenversicherers.<br>\\n\\nMindestens BMI 35<br>\\nNur für die Behandlung von adipösen Patienten. Die Behandlung muss nach 6 Monaten abgebrochen werden, wenn der Gewichtsverlust nicht mindestens 10% des Körpergewichts zu Beginn der Medikation beträgt. Bei Erreichen des Ziels wird die Therapie bis auf maximal 2 Jahre verlängert.<br>\\nVorgängige Kostengutsprache durch den Vertrauensarzt des Krankenversicherers.\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2007-01-01\"}]",
  "galenic_form": "Kaps 120 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1999-10-01",
  "self_retention_pct": 10
}

See everything about orlistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.